Health economics in the Hypertension Optimal Treatment (HOT) study: costs and cost-effectiveness of intensive blood pressure lowering and low-dose aspirin in patients with hypertension-Reference-Cited by-同舟云学术

Health economics in the Hypertension Optimal Treatment (HOT) study: costs and cost-effectiveness of intensive blood pressure lowering and low-dose aspirin in patients with hypertension

Published:2003-04 Issue:4 Volume:253 Page:472-480
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Jonsson B.,Hansson L.,Stalhammar N.-O.

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2796.2003.01135.x/fullpdf

Reference14 articles.

1. Cost Benefit of Treating Hypertension

2. The Hypertension Optimal Treatment (HOT) Study—Patient Characteristics: Randomization, Risk Profiles, and Early Blood Pressure Results

3. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial

4. Issues in the Cross-National Assessment of Health Technology

5. 5 FASS. Pharmaceuticals in Sweden (Pharmaceutical lexicon)[in Swedish]. Lakemedelsinformation AB. ISBN 91-85314-71-4, Stockholm1995 .

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiplatelet agents for chronic kidney disease;Cochrane Database of Systematic Reviews;2022-02-28

2. Low‐Dose Aspirin Treatment Attenuates Male Rat Salt‐Sensitive Hypertension via Platelet Cyclooxygenase 1 and Complement Cascade Pathway;Journal of the American Heart Association;2020-01-07

3. The Socioeconomic Effects of Uncontrolled Hypertension;Current Vascular Pharmacology;2017-12-15

4. Adherence to Therapy in the Outpatient Setting: the Ability to Identify and Assess the Effectiveness of Therapy;Kardiologiia;2017

5. Effects of low-dose aspirin in subjects with dyslipidemia;Lipids in Health and Disease;2016-06-16